Table II.
Linear regression model: factors associated with endorsement of buprenorphine and CBT treatment (n = 571).
| Standardized Parameter Estimate (95% CI) |
||
|---|---|---|
| Buprenorphine | CBT | |
| Demographics | ||
| Age (years) | 0.06 (0.00, 0.01) | 0.09 (0.01, 0.02)* |
| Race/ethnicity | ||
| White (reference) | – | – |
| African–American | –0.06 (–0.29, 0.02) | –0.09 (–0.51, –0.05)* |
| Native-American | 0.03 (–0.18, 0.49) | 0.02 (–0.35, 0.63) |
| Latino | –0.01 (–0.29, 0.20) | –0.03 (–0.50, 0.18) |
| Asian/P. Islander | –0.04 (–0.50, 0.14) | 0.01 (–0.40, 0.52) |
| Gender (ref: female) | 0.06 (0, 0.23) | 0.06 (–0.02, 0.31) |
| Provider type | ||
| Medical staff (ref.)a | – | – |
| Social workers | –0.15 (–0.42, 0.12)*** | 0.10 (0.06, 0.48)* |
| Psychologists | –0.10 (–0.34, –0.02)* | 0.01 (–0.19, 0.25) |
| Counsellors | –0.15 (–0.45, –0.13)*** | 0.01 (–0.19, 0.27) |
| Research involved | 0.09 (0.02, 0.34)* | 0.09 (0.03, 0.48)* |
| Training needs | ||
| Patient rapport | 0.11 (0.02, 0.14)** | –0.20 (–0.30, –0.12)*** |
| Patient management | –0.02 (–0.07, 0.04) | 0.09 (.002, 0.17)* |
| Patient needs | –0.02 (–0.07, 0.05) | 0.14 (0.06, 0.24)** |
| Attitudes | ||
| EBP | 0.18 (0.06, 0.14)*** | 0.13 (0.05, 0.16)*** |
| Knowledge | 0.07 (0, 0.05) | 0.03 (–0.02, 0.05) |
| Agency | ||
| Tech. capacity | –0.02 (–0.04, 0.02) | 0.02 (–0.03, 0.06) |
| Support growth | –0.04 (–0.04, 0.01) | –0.01 (–0.04, 0.03) |
Notes:
*
p < 0.05
**
p < 0.01
***
p < 0.001.
a
Medical staff is the reference group, and other groups are significantly lower in their endorsement as represented by the negative slope coefficient (counsellors having the lowest endorsement of all groups when compared with medical providers).